Lakeshore Biopharma (NASDAQ:LSB – Get Free Report) is projected to issue its quarterly earnings data before the market opens on Monday, January 27th. Analysts expect the company to announce earnings of ($0.80) per share for the quarter.
Lakeshore Biopharma Stock Up 12.9 %
Shares of NASDAQ:LSB opened at $2.63 on Friday. The stock has a 50 day moving average of $2.86. Lakeshore Biopharma has a twelve month low of $1.88 and a twelve month high of $11.20. The company has a quick ratio of 0.90, a current ratio of 1.17 and a debt-to-equity ratio of 0.13.
About Lakeshore Biopharma
See Also
- Five stocks we like better than Lakeshore Biopharma
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 3 Buy-and-Hold Stocks for Long-Term Growth
- What Investors Need to Know About Upcoming IPOs
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Lakeshore Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeshore Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.